Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer discovery

Showing results (601-610 of 4,678) with videos related to

Pageof 468
Sort By:
Cancer Discovery|July 23, 2013
A high-throughput functional complementation assay for classification of BRCA1 missense variantsPeter Bouwman, Hanneke van der Gulden, Ingrid van der Heijden, et al.
Cancer Discovery|July 31, 2015
DNA-PKcs Emerges as Master Driver of Metastasis
Cancer Discovery|December 6, 2014
NIH funds high-risk, high-reward research
Cancer Discovery|December 6, 2014
TKIs may be option for Ph-like ALL
Cancer Discovery|December 6, 2014
Expanding targeted therapies for NSCLC
Cancer Discovery|July 26, 2015
Pancreatic Cancer Metastases Harbor Evidence of PolyclonalityRavikanth Maddipati, Ben Z Stanger
Cancer Discovery|February 25, 2016
Tracking Tumor Evolution through MathematicsMitch Leslie
Cancer Discovery|December 9, 2015
Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal CancerMariangela Russo, Giulia Siravegna, Lawrence S Blaszkowsky, et al.
Cancer Discovery|December 6, 2015
RNF2 E3 or Not to E3: Dual Roles of RNF2 Overexpression in MelanomaJoshua C Black, Johnathan R Whetstine
Cancer Discovery|December 6, 2015
Infection and the Perils of B-cell ActivationMel Greaves, Markus Müschen
Pageof 468

Showing results (601-610 of 4,678) with videos related to

Sort By:
Pageof 468
Cancer Discovery|July 23, 2013
A high-throughput functional complementation assay for classification of BRCA1 missense variantsPeter Bouwman, Hanneke van der Gulden, Ingrid van der Heijden, et al.
Cancer Discovery|July 31, 2015
DNA-PKcs Emerges as Master Driver of Metastasis
Cancer Discovery|December 6, 2014
NIH funds high-risk, high-reward research
Cancer Discovery|December 6, 2014
TKIs may be option for Ph-like ALL
Cancer Discovery|December 6, 2014
Expanding targeted therapies for NSCLC
Cancer Discovery|July 26, 2015
Pancreatic Cancer Metastases Harbor Evidence of PolyclonalityRavikanth Maddipati, Ben Z Stanger
Cancer Discovery|February 25, 2016
Tracking Tumor Evolution through MathematicsMitch Leslie
Cancer Discovery|December 9, 2015
Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal CancerMariangela Russo, Giulia Siravegna, Lawrence S Blaszkowsky, et al.
Cancer Discovery|December 6, 2015
RNF2 E3 or Not to E3: Dual Roles of RNF2 Overexpression in MelanomaJoshua C Black, Johnathan R Whetstine
Cancer Discovery|December 6, 2015
Infection and the Perils of B-cell ActivationMel Greaves, Markus Müschen
Pageof 468